#Schedio Group#Acquire Lonza#Yahoo Finance#Finance Australia#Micro-Macinazione Site
#Agilent Technologies#Wall Street#Street Forecasters#Forecasters Revamp#Expectations Ahead
#Agilent Technologies#Partners Investment#Investment Management#Management Services#Reduces Stock
#Agilent Technologies#Handelsbanken Fonder#Buys#Shares#Technologies
#Technology Report#Purchase Clario#Enhance Clinical#Clinical Insights#Healthcare Technology
#Technologies Stock#Highs Ahead#Agilent Technologies#Stock#Eyeing
#Versant Ventures’#Dayra Therapeutics#Ventures’ latest#Therapeutics Versant#Versant macrocycle
#Agilent Technologies#Shares Sold#Rockefeller Capital#Capital Management#Technologies
#General Group#Agilent Technologies#Group Plc#Plc Reduces#Reduces Stake
#Agilent Technologies#Shares Sold#Mediolanum International#International Funds#Technologies
#win Bayer#high-profile failures#stock rallies#next-gen blood#blood thinner
#Novo Nordisk#closely-watched Alzheimer#long shot#long shots#Nordisk semaglutide
#Asundexian Phase#prevention Asundexian#study results#clinical setbacks#Phase
#Global Rollout#Stock Titan#Adopts Veeva#Veeva Vault#Vault CRM
#Announces Expanded#Expanded Partnership#Veeva Announces#Newswire Veeva#Announces
#Mikael Dolsten#Quarry Thera#Craig Crews#Dolsten raise#Mikael
#phase III#drugs Detailed#Detailed data#III study#scientific congress
#phase III#III Alzheimer#Novo Nordisk#treat Alzheimer#receptor agonist